Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia
100%
Ataxia Telangiectasia
44%
Tumor Suppressor Genes
43%
DNA Damage
37%
Methylation
36%
Synthetic Lethal Mutations
33%
Epigenomics
30%
Neoplasms
28%
transcription factor p120(E4F)
28%
parthenolide
22%
Neuroblastoma
19%
Microtubules
19%
AZD6738
18%
Heterografts
17%
Genes
16%
Genetic Promoter Regions
15%
Genomic Instability
14%
Human Herpesvirus 4
14%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14%
Cell Line
13%
Apoptosis
12%
Recombinational DNA Repair
12%
Enteropathy-Associated T-Cell Lymphoma
12%
Tankyrases
12%
Breast Neoplasms
12%
CpG Islands
11%
Cyclin A2
11%
In Vitro Techniques
11%
Azacitidine
11%
Ubiquitin-Specific Proteases
10%
aniline
10%
Ribonucleotides
10%
T-Lymphocytes
10%
Proteins
10%
Therapeutics
10%
Suppressor Genes
10%
Toll-Like Receptor 9
10%
Lymphoma
9%
Epstein-Barr Virus Infections
9%
Double-Stranded DNA Breaks
9%
Protein Isoforms
9%
Adenoviridae Infections
9%
Alleles
9%
Non-Small Cell Lung Carcinoma
9%
Pediatrics
9%
Lung
8%
Poly(ADP-ribose) Polymerases
8%
Microtubule-Associated Proteins
8%
Carcinoma, Intraductal, Noninfiltrating
8%
Non-Hodgkin's Lymphoma
8%